Susanne Kimeswenger

View Scopus Profile

Emailsusanne.kimeswengerjkuat

Personalized biologic treatments for patients with Darier disease result in varying responses
Ettinger, M., Burner, T., Lackner, A., Deli, I., Traxler, J., Altrichter, S., Gratz, I. K., Kimeswenger, S., Guenova, E. & Hoetzenecker, W., Mar 2026, In: Journal of the European Academy of Dermatology and Venerology. 40, 3, p. 513-516 4 p.
Research output: Contribution to journal › Article › peer-review
Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., Kausche, L., Firsching, T. C., Dietert, K., Schotsaert, M., Martínez-Romero, C., Singh, G., Kunz, S., Niemeyer, D., Ghanem, R. & Salzer, H. J. F. & 28 others, Paar, C., Mülleder, M., Uccellini, M., Michaelis, E. G., Khan, A., Lau, A., Schönlein, M., Habringer, A., Tomasits, J., Adler, J. M., Kimeswenger, S., Gruber, A. D., Hoetzenecker, W., Steinkellner, H., Purfürst, B., Motz, R., Di Pierro, F., Lamprecht, B., Osterrieder, N., Landthaler, M., Drosten, C., García-Sastre, A., Langer, R., Ralser, M., Eils, R., Reimann, M., Fan, D. N. Y. & Schmitt, C. A., Feb 2025, In: Nature. 638, 8052, p. E46 1 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Evidence of immunogenic cell death (ICD) and ICD-dependent dendritic cell activation induced by extracorporeal photopheresis in patients with leukaemic forms of cutaneous T-cell lymphoma
Lackner, A., Burner, T., Huber, M., Dey, S., Aigner, S., Buxhofer-Ausch, V., Geroldinger-Simic, M., Iselin, C., Chang, Y.-T., Tsai, Y.-C., Altrichter, S., Wolf, P., Kimeswenger, S., Guenova, E. & Hoetzenecker, W., 17 Jul 2025, In: British Journal of Dermatology. 193, 2, p. 276-286 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Rapid Change in FcεRI Occupancy on Basophils After Venom Immunotherapy Induction
Puxkandl, V., Aigner, S., Burner, T., Lackner, A., Moñino-Romero, S., Kimeswenger, S., Hoetzenecker, W. & Altrichter, S., 04 Aug 2025, In: International Journal of Molecular Sciences. 26, 15, 16 p., 7511.
Research output: Contribution to journal › Article › peer-review

Open Access
A case of papular acantholytic dyskeratosis with IL-23/TNF-α dominant immune profile
Ettinger, M., Burner, T., Lackner, A., Guenova, E., Kimeswenger, S. & Hötzenecker, W., Feb 2024, In: Journal der Deutschen Dermatologischen Gesellschaft. 22, 2, p. 274-276 3 p.
Research output: Contribution to journal › Article › peer-review

2 Active
10 Finished

IJAMP: A mechanistic study to determine the influence of topical JAK-Inhibitor Ruxolitinib treatment on mastcell function and standard allergy test performance
Hötzenecker, W. (Co-PI), Kimeswenger, S. (Researcher) & Altrichter, S. (PI)
03.07.2025 → 30.04.2027
Project: Clinical studies › Clinical Study (Funded research)
Molecular Mechanism of Darier Disease
Kimeswenger, S. (Researcher), Wagner, T. (Researcher) & Hötzenecker, W. (PI)
01.01.2023 → 31.12.2026
Project: Other › Project from scientific scope of research unit
ORTH3D: Pilotstudie: Erstellen und testen einer digitalisierten 3D gedruckten Orthese zur Skoliosebehandlung
Kimeswenger, S. (Researcher), Hötzenecker, W. (PI) & Puxkandl, V. (Researcher)
01.10.2024 → 30.09.2025
Project: Funded research › FFG - Austrian Research Promotion Agency
Understanding extracorporeal photopheresis
Brandner, M. (Researcher), Kimeswenger, S. (Researcher), Lackner, A. (Researcher) & Hötzenecker, W. (PI)
30.01.2024 → 30.01.2024
Project: Other › Project from scientific scope of research unit
RARE-AI: Using artificial intelligence to predict the diagnosis and outcome of the rare malignancy cutaneous T cell lymphoma
Haddady, S. (Researcher), Hötzenecker, W. (Researcher) & Kimeswenger, S. (PI)
26.07.2023 → 25.07.2025
Project: Funded research › Federal / regional / local authorities

5 Invited talk
4 Contributed talk
2 Poster presentation

Patient with ADAM17 mutation-caused Neonatal Inflammatory Skin and Bowel Disease 1 responds to personalized treatment with IL-12/IL-23 blocking antibody
Kimeswenger, S. (Speaker)
21 Nov 2025
Activity: Talk or presentation › Invited talk › science-to-science
Skin-immune system interactions in Darier disease
Kimeswenger, S. (Speaker)
07 Oct 2025
Activity: Talk or presentation › Contributed talk › science-to-science
Altered Ca2+ homeostasis in keratinocytes of Darier disease patients contributes to Th17-dominated skin infiltrate
Kimeswenger, S. (Speaker)
15 Mar 2025
Activity: Talk or presentation › Contributed talk › science-to-science
Patient with ADAM17 mutation-caused Neonatal Inflammatory Skin and Bowel Disease responds to personalized treatment with IL-12/IL-23 blocking antibody (Ustekinumab)
Kimeswenger, S. (Speaker)
13 Mar 2025
Activity: Talk or presentation › Contributed talk › science-to-science
Interpretability of Neural Networks for Dermatohistopathology
Hötzenecker, W. (Speaker) & Kimeswenger, S. (Speaker)
08 Sept 2022
Activity: Talk or presentation › Invited talk › science-to-science

Translational research prize of the ADF
Kimeswenger, S. (Recipient), 2021
Prize: Prize, award or honor

Susanne Kimeswenger

Research output

Projects

Activities

Prizes